Abstract
A scalable C–O bond formation via continuous-flow Ni-electrocatalysis was developed, enabling the gram-scale preparation of a key delamanid intermediate, a pharmaceutical used to treat multidrug-resistant tuberculosis.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have